Skip to content
Review

Aromatic Sulfonamides Emerge as a Promising Frontier in Advanced Cancer Therapy.

Sep 2026 · Current Medicinal Chemistry · Vol 33 · 0 citations
Medicine

TL;DR

The available evidence indicates that structural optimization of aromatic sulfonamides can improve antiproliferative activity and target selectivity, although cellular potency alone is insufficient to establish therapeutic relevance.

Abstract

INTRODUCTION/

Objective

Current cancer chemotherapy is limited by severe adverse effects, poor selectivity toward malignant cells, and the emergence of multidrug resistance, highlighting the need for novel therapeutic strategies with enhanced potency and safety. Sulfonyl-containing compounds and sulfonamide derivatives have attracted sustained attention as anticancer scaffolds because of their structural diversity, favorable physicochemical properties, and broad pharmacological profiles. This review critically examines how structural variation within aromatic sulfonamides controls target engagement, anticancer activity, and translational potential. Rather than cataloguing individual derivatives, it integrates cross-family structure-activity relationships with mechanistic evidence involving carbonic anhydrases, tubulin dynamics, survival signaling, apoptosis, and tumorassociated metabolic adaptation.

Methods

Recent experimental and preclinical studies were reviewed, with special emphasis on sulfonyl and sulfonamide derivatives as multifunctional pharmacophores and their emerging role in cancer therapy, supported by extensive chemical and pharmacological evidence. Emphasis was placed on heterocyclic sulfonyl compounds and macrocyclic hybrid systems.

Results

Several sulfonamide derivatives have demonstrated potent antiproliferative activity against a broad range of human cancer cell lines, including MCF-7 and MIA PaCa-2, by interacting with multiple targets and disrupting pathways involved in tumor growth and survival. Calixarenesulfonyl hybrids demonstrate selective and potent cytotoxicity against several cancer cell lines, including breast and pancreatic cancer models. These compounds inhibit tubulin dynamics, reduce the proliferation of multiple human cancer cell lines, induce apoptosis, and modulate molecular targets associated with the phosphoinositide 3-kinase/protein kinase B signaling pathway. The clinical success of sulfonamide-containing agents further validates this pharmacophore in oncology.

Discussion

The available evidence indicates that structural optimization of aromatic sulfonamides can improve antiproliferative activity and target selectivity, although cellular potency alone is insufficient to establish therapeutic relevance. Direct target validation, mechanistic characterization, tumor selectivity, and pharmacokinetic assessment remain necessary to distinguish pharmacologically relevant activity from non-specific cytotoxicity.

Conclusion

Aromatic sulfonamides constitute a chemically adaptable platform from which compounds acting on carbonic anhydrases, tubulin, survival signaling, and apoptosis-related processes have been developed. The available evidence supports their continued investigation in anticancer drug discovery; however, multi-target activity should be considered advantageous only when target engagement, tumor selectivity, and resistance-relevant effects are experimentally distinguished from non-specific cytotoxicity. Future development will depend on biomarker-guided evaluation, direct mechanistic validation, and early assessment of pharmacokinetic and safety liabilities.

View source

Similar papers

Review Open access Sep 2026

A Review Studies of Sulfonamide as Multifunctional Agents from Antibacterial Activity to Anticancer Application

This review covers current breakthroughs in sulfonamide derivative production, biological activity, resistance mechanisms, and therapeutics and nanotechnology, AI-assisted drug discovery, and multitarget therapy design which increase sulfonamide-based treatment selectivity and efficacy.

Dina Saleem, Hawazin Aziz Hamim, Sura S. Raoof · 0 citations
Review Aug 2026

Pyrimidine-containing Heterocyclic Anticancer Agents: Systematic Development, SAR, and Mechanistic Pathways.

Pyrimidine-containing hybrids emerge as a privileged scaffold in medicinal chemistry for the development of effective, multitargeted anticancer agents with improved pharmacological profiles and reduced off-target effects.

Bhim Singh, Ankita Devi, V. Jaitak · 0 citations
Review Sep 2026

Purine Derivatives in Cancer Therapy: Structure-Activity Relationships and Recent Advances in Anticancer Drug Development

Cancer remains one of the most serious global health challenges, characterized by uncontrolled cellular proliferation resulting from diverse genetic, metabolic, and immunological alterations. Conventional therapies, such as chemotherapy, radiotherapy, and hormonal treatments, though widely used, are often associate...

Parminder Kaur, Shagun Aggarwal, Navneet Sharma · 0 citations
Review Aug 2026

Recent Developments in Triazolopyrimidine-based Cancer Therapeutics: A Mini Review.

This review critically summarizes and discusses the progress made in the design, synthesis, and anticancer evaluation of triazolopyrimidine-based organic and inorganic scaffolds reported in the scientific literature over the past five years, with an emphasis on their mechanisms of action and future therapeutic prospect...

I. Lumb, Jaskirat Singh, Yukta Soni et al. · 0 citations
Review Oct 2026

Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development.

Cancer remains a global health challenge with high morbidity and mortality, and the clinical application of conventional anticancer agents is severely limited by issues such as poor selectivity, systemic toxicity, and multidrug resistance. Chalcones, pyridines, and pyrimidines are privileged heterocyclic scaffolds in m...

Jun-Jian Wang, Lu-Mei Dai, Shi-Fang Wen et al. · 0 citations
Review Oct 2026

Thiazole-based Anticancer Agents: Synthetic Strategies, Molecular Mechanisms, Comparative Structure-activity Relationships, and Rational Design Perspectives.

Cancer continues to represent a major global health challenge, prompting the search for new therapeutic agents with improved efficacy and reduced toxicity. Among heterocyclic scaffolds, thiazole has attracted considerable attention in medicinal chemistry because of its structural versatility, synthetic accessibility, a...

Lovish Sharma, Ankur Thakur, Rohit Bhatia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.